Interstitial T1-weighted MR Lymphography: Lipophilic Perfluorinated Gadolinium Chelates in Pigs
- 1 July 2001
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 220 (1) , 129-134
- https://doi.org/10.1148/radiology.220.1.r01jl04129
Abstract
To investigate the enhancement of the regional lymph nodes, lymphatic vessels, and thoracic duct after interstitial administration of lymphotropic perfluorinated gadolinium chelates at magnetic resonance (MR) imaging. Two perfluorinated gadolinium chelates, gadofluoramide and gadofluorine 8, were injected subcutaneously into the hind legs of 10 pigs, respectively. Both contrast media were studied at doses of 10 and 25 micromol per kilogram of body weight. T1-weighted three-dimensional gradient-echo and maximum intensity projection images were obtained at 1.5 T between 1 and 210 minutes and 24 hours after injection. The contrast agents were qualitatively compared regarding enhancement and depiction of the regional lymph nodes, lymphatic vessels, and thoracic duct. The inguinal and iliac lymph nodes and lymphatic vasculature enhanced substantially within 10 minutes after subcutaneous administration of both lymphotropic contrast agents. Gadofluorine 8 showed a lymphographic effect superior to that of gadofluoramide. The paraaortic lymph nodes and thoracic duct were best visualized 10--50 minutes after injection of 25 micromol/kg of gadofluorine 8. Lymphatic system enhancement diminished after 2 hours, and the liver and bowel tract enhanced within 24 hours. Interstitial administration of perfluorinated gadolinium chelates offers great potential for T1-weighted MR lymphography with positive enhancement of the lymph nodes and lymphatic vasculature.Keywords
This publication has 26 references indexed in Scilit:
- Iron oxide-enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancerJournal of Magnetic Resonance Imaging, 1997
- MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (combidex): Preliminary observationsJournal of Magnetic Resonance Imaging, 1997
- Characterization of Reactive Versus Tumor-Bearing Lymph Nodes with Interstitial Magnetic Resonance Lymphography in an Animal ModelInvestigative Radiology, 1995
- Investigation of Mechanisms Influencing the Accumulation of Ultrasmall Superparamagnetic Iron Oxide Particles in Lymph NodesInvestigative Radiology, 1995
- Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast propertiesMagnetic Resonance Imaging, 1995
- MR Lymphography with a Lymphotropic T1‐Type MR Contrast Agent: Gd‐DTPA‐PGMMagnetic Resonance in Medicine, 1995
- Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.American Journal of Roentgenology, 1993
- Monocrystalline iron oxide nanocompounds (MION): Physicochemical propertiesMagnetic Resonance in Medicine, 1993
- Particle sizing and biokinetics of interstitiallymphoscintigraphic agentsSeminars in Nuclear Medicine, 1983
- LymphangiographyBMJ, 1955